Your browser doesn't support javascript.
loading
Cetuximab ± chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro.
Correale, P; Botta, C; Cusi, M G; Del Vecchio, M T; De Santi, M M; Gori Savellini, G; Bestoso, E; Apollinari, S; Mannucci, S; Marra, M; Abbruzzese, A; Aquino, A; Turriziani, M; Bonmassar, L; Caraglia, M; Tagliaferri, P.
Affiliation
  • Correale P; Medical Oncology Unit, Department of Oncology, Siena University Hospital, Istituto Toscano Tumori, Siena, Italy. correalep@yahoo.it
Int J Cancer ; 130(7): 1577-89, 2012 Apr 01.
Article in En | MEDLINE | ID: mdl-21618510

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phagocytosis / Dendritic Cells / T-Lymphocytes, Cytotoxic / Antineoplastic Combined Chemotherapy Protocols / Colonic Neoplasms / Antibodies, Monoclonal Limits: Humans Language: En Journal: Int J Cancer Year: 2012 Type: Article Affiliation country: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phagocytosis / Dendritic Cells / T-Lymphocytes, Cytotoxic / Antineoplastic Combined Chemotherapy Protocols / Colonic Neoplasms / Antibodies, Monoclonal Limits: Humans Language: En Journal: Int J Cancer Year: 2012 Type: Article Affiliation country: Italy